A Long-Term Registry of Humira ® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Read time: 1 mins
Last updated:3rd May 2013
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
|Study start date||2013-05-03|